Nivolumab,Relatlimab
BMS
['relatlimab', 'nivo']
the #oncoalerttoptweet day 2 #asco23 tweet by faculty next up in neoadj space is nivo-relatlimab (lag3) 80mg. nice to see this p2 window study. 95% r0. best, 
🌐 Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees 🌎 We are #OncoAlert 🚨